These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6356227)

  • 1. The design, synthesis and development of a new class of potent antineoplastic anthraquinones.
    Cheng CC; Zee-Cheng RK
    Prog Med Chem; 1983; 20():83-118. PubMed ID: 6356227
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitoxantrone (novantrone): a review of experimental and early clinical studies.
    Smith IE
    Cancer Treat Rev; 1983 Jun; 10(2):103-15. PubMed ID: 6347376
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.
    Jin GZ; Jin HS; Jin LL
    Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia.
    Prentice HG; Robbins G; Ma DD; Ho AD
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():57-63. PubMed ID: 6362878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone in relapsed and refractory acute leukemia.
    Prentice HG; Robbins G; Ma DD; Ho AD
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):32-5. PubMed ID: 6385263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase.
    Perry PJ; Gowan SM; Reszka AP; Polucci P; Jenkins TC; Kelland LR; Neidle S
    J Med Chem; 1998 Aug; 41(17):3253-60. PubMed ID: 9703471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone: a new anticancer drug with significant clinical activity.
    Shenkenberg TD; Von Hoff DD
    Ann Intern Med; 1986 Jul; 105(1):67-81. PubMed ID: 3521429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone: a promising new chemotherapeutic agent.
    Dalton WS; Alberts DS
    Ariz Med; 1984 Feb; 41(2):96-8. PubMed ID: 6703919
    [No Abstract]   [Full Text] [Related]  

  • 9. Esters of 2-(1-hydroxyalkyl)-1,4-dihydroxy-9,10-anthraquinones with melphalan as multifunctional anticancer agents.
    Jin G; You Y; Ahn B
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1473-6. PubMed ID: 11378380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic and biochemical effects of mitoxantrone.
    Durr FE
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):3-10. PubMed ID: 6484579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Moore JO; Olsen GA
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):41-6. PubMed ID: 6385265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature effect on mitoxantrone cytotoxicity in Chinese hamster cells in vitro.
    Yang SJ; Rafla S
    Cancer Res; 1985 Aug; 45(8):3593-7. PubMed ID: 4016740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone.
    Nathanson L
    Cancer Treat Rev; 1984 Dec; 11(4):289-93. PubMed ID: 6534511
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mitoxantrone--a new cytostatic agent].
    Klein HO
    Fortschr Med; 1985 Feb; 103(8):229-30. PubMed ID: 3979939
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic activity of mitoxantrone and ametantrone against murine tumors.
    Schabel FM; Corbett TH; Griswold DP; Laster WR; Trader MW
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():13-21. PubMed ID: 6362874
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of 9,10-anthracenedione, 1,4-bis[(2-[(2-hydroxyethyl)amino]-ethyl)amino]-diacetate on cell survival and cell cycle progression in cultured mammalian cells.
    Evenson DP; Darzynkiewicz Z; Staiano-Coico L; Traganos F; Melamed MR
    Cancer Res; 1979 Jul; 39(7 Pt 1):2574-81. PubMed ID: 286637
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of the structure of amino-substituted anthraquinones to cytotoxicity in cultured Chinese hamster cells.
    Kimler BF; Cheng CC; Barnes RE; Barnes ML
    Invest New Drugs; 1983; 1(3):213-8. PubMed ID: 6687221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship study of anthraquinones: 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethoxy)ethyl]amino]-9,10-anthracenedione, an analog of an established antineoplastic agent.
    Zee-Cheng RK; Cheng CC
    J Pharm Sci; 1982 Jun; 71(6):708-9. PubMed ID: 7097541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mitoxantrone and ametantrone in human acute myelocytic leukemia cells in culture and in bone marrow granulocyte-macrophage progenitor cells.
    Fountzilas G; Ohnuma T; Rammos K; Mindich B; Holland JF
    Cancer Drug Deliv; 1986; 3(2):93-100. PubMed ID: 3458518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.